Drug · DIN 02443643
EPERZAN
SINGLE-USE DUAL CHAMBER PREFILLED PEN
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since October 24, 2017.
- Drug Identification Number (DIN)
- 02443643
- Company (DIN owner)
- Glaxosmithkline IncMississauga, Ontario, Canada
- Schedule
- Schedule d; Prescription
- Dosage form
- Powder For Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Albiglutide A10BJ04
- Class
- Human
- Record last updated
- August 21, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ALBIGLUTIDE | 50 MG | 0.5 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 15, 2015: NOC 17080New Drug Submission (NDS)
Other DINs named EPERZAN
- DIN 02443635 · Cancelled Pre Market